Musunuri Shankar 4
4 · Ocugen, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Musunuri Shankar
DirectorChief Executive Officer
Transactions
- Award
Option (Right to Buy)
2024-01-02+492,126→ 492,126 totalExercise: $0.66Exp: 2034-01-02→ Common Stock (492,126 underlying)
Footnotes (1)
- [F1]The option vests annually in equal installments over three years commencing on January 2, 2025, subject to continued service with the Issuer on the applicable vesting dates.